SOLID DISPERSIONS AND PHARMACEUTICAL COMPOSITIONS INCLUDING SUBSTITUTED INDANE, AND METHODS FOR PRODUCTION AND APPLICATION THEREOF Russian patent published in 2022 - IPC A61K31/10 A61K31/275 A61K9/10 A61K9/20 A61K9/48 A61P35/00 

Abstract RU 2772693 C1

FIELD: pharmaceuticals.

SUBSTANCE: group of inventions relates to an HIF-2α-inhibiting pharmaceutical solid dosage form for oral administration of a compound by the formula (I)

Formula (I),

and to methods for treatment including administration of said dosage form. The solid dosage form includes a solid dispersion including a compound by the formula (I) and one or more pharmaceutically acceptable excipients. The solid dispersion therein includes a pharmaceutically acceptable polymer selected from the group consisting of hydroxypropyl methylcellulose acetate (HPMCAS), cellulose acetate phthalate (CAP), and a polyethylene glycol-polyvinyl acetate-polyvinyl caprolactam graft copolymer, and the solid dosage form constitutes a capsule or tablet. Also claimed is a method for treating von Hippel-Lindau disease (VHL) and a method for treating renal cell carcinoma.

EFFECT: invention increases the stability, bioavailability, and quality of storage of the pharmaceutical dosage form.

18 cl, 15 dwg, 33 tbl, 18 ex

Similar patents RU2772693C1

Title Year Author Number
COMPOUNDS AND COMPOSITIONS FOR STABILISATION OF HYPOXIA INDUCED FACTOR-2 ALPHA AS METHOD OF CANCER MEDICAL TREATMENT 2012
  • Shalvitz Robert
  • Marsh Klej
  • Roda Dzhuli
  • Jubenk Timoti
RU2602498C2
IMPROVED THERAPEUTIC INDEX OF INHIBITORS AGAINST IMMUNE CHECKPOINT USING COMBINATION THERAPY INCLUDING PHY906 EXTRACT, SCUTELLARIA BAICALENSIS GEORGI (S) EXTRACT OR COMPOUND OF SUCH EXTRACTS 2017
  • Cheng, Yung-Chi
  • Chen, Lieping
RU2753523C2
CRF1 RECEPTOR ANTAGONIST, PHARMACEUTICAL FORMULATIONS AND SOLID FORMS FOR TREATING CONGENITAL ADRENAL HYPERPLASIA 2019
  • Farber, Robert Kh.
  • Loeven, Gordon Rafael
  • Chzhan, Syaopin
  • Giri, Nagdip
  • Chan, Dzhin L.
  • Stirn, Skott
  • Sajers, Brajan
  • Tejlor, Grem
  • Kosta, Kristina Mari
  • Parks, Stejsi
  • Vikeri, Entoni D.
  • Dauning, Kristi M.
  • Ajokha, Kingsli
  • Ngvenya-Dzhons, Ajanda
  • Sharle, Ann
  • Mekhton, Gurvinder Singkh
RU2824490C2
PHARMACEUTICAL COMPOSITION AND ITS ADMINISTERING 2013
  • Dokou, Eleni
  • Jamzad, Shahla
  • Caesar, John, P., Jr.
  • Fawaz, Majed
  • Das, Laura
  • Gu, Chong-Hui
  • Hurter, Patricia, Nell
  • Israni, Meghna, Jai
  • Johnston, Meghan, M.
  • Knezic, Dragutin
  • Kuzmission, Andrew, G.
  • Wang, Hongren
RU2802442C2
PHARMACEUTICAL COMPOSITION AND INTRODUCTION THEREOF 2013
  • Dokou Eleni
  • Dzhamzad Shakhla
  • Kaesar Dzhon P. Ml.
  • Favaz Madzhed
  • Das Laura
  • Gu Chun-Khoj
  • Kherter Patrisiya Nell
  • Israni Megkhna Dzhaj
  • Dzhonston Megan M.
  • Knezich Dragutin
  • Kuzmission Endryu G.
  • Van Khunzhen
RU2692779C2
METHODS FOR INCREASING STABILISATION OF HYPOXYA INDUCED FACTOR-1 ALPHA 2010
  • Shalvits Robert
  • Gardner Dzhozef Kh.
RU2521251C2
METHOD FOR REDUCING MULTI-DRUG RESISTANCE WITH USING INOSITOL TRIPYROPHOSPHATE 2010
  • Nikolau Iv Klod
  • Len Zhan-Mari
  • Kieda Klodin
RU2563127C2
NANOPARTICLE, CONTAINING RAPAMYCIN AND ALBUMIN AS ANTI-CANCER AGENT 2008
  • Disehj Nejl P.
  • Soon-Shiong Patrik
  • Trieu Vuong
RU2483714C2
PHARMACEUTICAL COMBINATIONS 2017
  • Caponigro, Giordano
  • Cao, Zhu Alexander
RU2759669C2
SOLID DISPERSIONS 2016
  • Chen, Chzhenmin
  • Chen, Syaomin
  • Khalloran, Kevin
RU2694832C2

RU 2 772 693 C1

Authors

Lindemann, Christopher

Stengel, Peter J.

Dates

2022-05-24Published

2019-10-23Filed